secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2024-03-27T23:59:59+00:00
Accession:  0001193125-24-078226
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics receives Nasdaq delisting notices; plans to appeal
----------------------------------------------------------------------

- March 21 notice: failed to meet $50M MVLS and $1.00 bid price for 30 consecutive days.
- March 26 notice: failed to meet $15M market value of publicly held shares requirement.
- Company will request hearings by March 28 and April 2 deadlines; stay pending outcome.
- May request transfer to Nasdaq Capital Market; no guarantee of approval or continued listing.
- Common stock (GRTX) expected to remain listed at least until Panel decision.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312524078226/0001193125-24-078226-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312524078226/d797057d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-078226

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer